Introduction
Adequate iron, vitamin A, and zinc nutrition are important for cognitive development and child survival (1) . However, infants and young children in developing countries are especially vulnerable to deficiencies of these micronutrients owing to low micronutrient stores at birth, low breast milk content (especially after 6 mo postpartum), inadequate intake of bioavailable micronutrients from complementary foods, and/or increased micronutrient requirements because of infection. To assess the prevalence of micronutrient deficiencies in a population and evaluate the effects of nutrition interventions, valid and reliable biomarkers of nutrient exposure (intake), status, function, and effect are needed.
Current biomarkers of iron storage [plasma ferritin (pF)] 6 , iron sufficiency for erythropoiesis [transferrin saturation, hepcidin, soluble transferrin receptor (sTfR), and zinc protoporphyrin], iron deficiency (ID) anemia [hemoglobin (Hb)] reflect different physiologic processes and stages of iron depletion and functional ID (2) . In addition, the aforementioned iron indicators, as well as indicators of vitamin A and zinc status [retinol, retinol-binding protein (RBP), plasma zinc (pZn)], are differentially affected by the acute phase response and/or malaria infection, complicating the interpretation of results and reducing their usefulness in populations where infection and inflammation are prevalent (3) (4) (5) (6) (7) .
For those nutritional biomarkers that are acute phase proteins (APP; e.g., pF, RBP) or affected by the acute phase response (e.g., retinol, pZn), it is possible to adjust measured micronutrient concentrations statistically for the effects of elevated APPs [e.g., C-reactive protein (CRP) and a-1-acidglycoprotein (AGP)], with the use of a published correction method, which categorizes asymptomatic individuals by their inflammatory state based on different phases of infection (incubation, early convalescence, later convalescence, and reference) as defined by elevated CRP only, CRP and AGP, AGP only, or neither, respectively (3, 5, 8) . However, this method only controls for the effects of specific infections and inflammatory processes insofar as they lead to an increase in circulating CRP and AGP; it does not account for any additional or independent effects of specific infections, such as asymptomatic malaria infection, on micronutrient metabolism, which may differentially affect the interpretation of biomarkers of nutritional status. Independent of the acute phase response, hemolysis of RBCs and dyserythropoiesis (suppressed heme production despite anemia) during asymptomatic malaria infection may paradoxically increase the proportion of body iron present as iron stores (pF concentrations) from recycled iron (9, 10) . In addition, sTfR concentrations reflect not only iron sufficiency for erythropoiesis, but also the rate of erythropoiesis, which may be elevated by hemolytic conditions, as with subclinical malaria infections (7) . In fact, 2 recent studies have noted differences in Hb, pF, sTfR, and/or zinc protoporphyrin between those with and without asymptomatic malaria after correcting for APP (11) or when stratifying participants by APP and malaria status (12) . However, it is unknown if these estimates were simply affected by intracategory differences in APP among those with and without asymptomatic malaria, or if they were specifically associated with malaria. In addition, reductions in RBP and retinol have been previously observed with both symptomatic and asymptomatic malaria, although they were largely attributed to metabolic changes caused by the inflammatory response, rather than malaria-specific effects (13) (14) (15) .
The objectives of the present analyses were to explore the associations among APP, asymptomatic malaria, and indicators of micronutrient nutritional status (Hb, pF, sTfR, RBP, pZn) and to examine how the relation between the APP and micronutrient indicators are modified by asymptomatic malaria in a holoendemic region. In addition, we examined the effects of elevated APP and asymptomatic malaria on the estimated prevalence of deficiencies, the relation between different biomarkers of iron status, and the extent to which correction factors modulated these relations.
Methods
Study population. The current analyses are based on baseline data obtained from a randomized controlled trial designed to investigate the efficacy of different formulations of preventive zinc supplements on change in pZn concentrations. Detailed descriptions of the study population and methods, as well as the overall effect of the intervention on pZn, have been published elsewhere (16) . In brief, the study was conducted among 451 young children from 31 rural communities in southwestern Burkina Faso from September to December 2009. Infants and young children were invited to participate in the study if they met the following inclusion criteria: residing within the catchment area of the Toussiana governmental health clinic, age 6-23 mo, currently breastfeeding and Hb $ 60 g/L. Children who were currently consuming vitamin or mineral supplements or zinc-fortified infant formulas or who demonstrated bipedal edema or other serious medical conditions were excluded. Children with acute symptomatic illnesses [e.g., fever or diarrhea (more than 3 liquid or semiliquid stools in a 24 h period) reported by a caregiver in the 7 d before screening or an axillary temperature >37.5°C at the time of screening] were excluded temporarily and rescreened at least 1 wk after recovery. The protocol of the clinical trial was approved by the Institutional Review Boards of the Center Muraz in Bobo-Dioulasso, Burkina Faso, and the University of California, Davis, and registered as a clinical trial (www.ClinicalTrials. gov; NCT00944853). Consent materials were presented, both orally and in writing, in the presence of a neutral witness. Informed consent, documented by either a written signature or a fingerprint, was obtained from a parent of each child before enrollment in the study.
Biochemical assessments. Ten microliters of capillary blood was drawn directly into HemoCue microcuvettes, and Hb concentration was analyzed immediately through the use of a HemoCue 201+ photometer (HemoCue AB) to assess eligibility. When a childÕs Hb concentration was $60 g/L, an additional 5 mL of blood was drawn from an antecubital or dorsal metacarpal vein by a trained phlebotomist, following procedures recommended by the International Zinc Nutrition Consultative Group (17) . Venous blood was collected in evacuated, trace element-free polyethylene tubes containing lithium heparin (Sarstedt AG & Co.), and stored immediately at 4°C. Within 8 h of collection, plasma was separated from heparinized blood by centrifuging samples at 1520 3 g for 10 min at 4°C. Plasma aliquots were subsequently stored at 220°C and then shipped on dry ice to the United States and Germany for laboratory analysis.
Laboratory analyses. The pF, sTfR, RBP, CRP, and AGP concentrations were measured with the use of a combined sandwich ELISA technique at the VitA-Iron Lab (Willstaett, Germany) (18) . All samples were measured in duplicate; the interassay CV for a control sample ranged from 2.6% to 4.1%. pZn concentrations were analyzed by inductively coupled plasma optical emission spectrophotometry (Vista; Varian, Inc.) at the ChildrenÕs Hospital of Oakland Research Institute (Oakland, California); detailed methods and results have been reported previously (16) . Histidine-rich protein II (HRP2) is expressed by Plasmodium falciparum trophozoites and released into the plasma during the erythrocytic stages of malarial parasitemia; plasma HRP2 concentrations are indicative of current or recent malaria parasitemia (19) . Plasma HRP2 concentrations were measured with the use of a commercially available CELISA kit (Cellabs Pty, Ltd.), following the manufacturerÕs instructions. Single plasma samples were initially analyzed on plates with positive and negative controls provided by the manufacturer; samples with an absorbance value greater than the optical density of the negative control +0.05 U were considered presumptively positive for P. falciparum antigen and reanalyzed to quantify the HRP2 concentration of the samples. For these analyses, the positive control was serially diluted in Roswell Park Memorial Institute media (RPMI-1640, no glutamine; Life Technologies), and concentrations ranging from 0.43 to 27.5 mg/L were plated in duplicate to construct a standard curve. As necessary, samples were diluted in PBS/Tween to obtain values within the limits of the standard curve and then plated in duplicate. Samples with an absorbance value greater than the optical density of the negative control +0.1 U were considered definitively positive. The detection limit of the positive control was 0.75 mg/L and the CV was 9.3% (1:16 dilution run on all plates). Children with plasma HRP2 concentrations above the detection limit of the positive control are henceforth referred to as having asymptomatic malaria.
Statistical analyses. Descriptive statistics were calculated for all variables; variables not normally distributed (Shapiro-Wilk statistic, W < 0.97) were transformed before subsequent analysis. Biomarkers were adjusted for the presence of elevated APP in an attempt to remove the confounding effect of subclinical inflammation in the assessment of nutritional status and deficiency. Group-specific adjustment factors were calculated for each biomarker as the ratios of the mean (when normally distributed) or geometric mean value of the biomarker for the reference group (CRP < 5 mg/L, AGP < 1 g/L) to the incubation (CRP $ 5 mg/L, AGP < 1 g/L), early convalescence (CRP $ 5 mg/L, AGP $ 1 g/L), and late convalescence (CRP < 5 mg/L, AGP $ 1 g/L) groups (3) . Individual values were then multiplied by their biomarker-and group-specific adjustment factors to create an adjusted concentration. Additionally, 8 group-specific biomarker adjustment factors were created as detailed previously, accounting for both APP and HRP2 status; individuals with HRP2 concentrations $0.75 mg/L were considered positive for asymptomatic malaria (reference group: CRP < 5 mg/L, AGP < 1 g/L, HRP2 < 0.75 mg/L).
ID was variously defined as pF < 12 mg/L (unadjusted and adjusted), pF < 30 mg/L (unadjusted) (20, 21) , sTfR > 8.3 mg/L (18), and sTfR > 10.3 (cutoff based on 97.5th percentile sTfR concentrations among Zimbabwean children #24 mo of age) (22) . Anemia was defined as Hb < 11 g/dL (21) . Vitamin A and zinc deficiencies were defined as RBP < 0.84 mmol/L (23, 24) and pZn < 65 mg/dL (25), respectively.
Group-wise differences in concentrations of biomarkers of nutritional status, infection, and inflammation (e.g., by age, sex, APP, and/or HRP2 status) were assessed through the use of t tests or ANOVA as appropriate. Group means from ANOVA models were compared post hoc with the use of least-square means with the Tukey-Kramer adjustment for multiple comparisons. The prevalence of micronutrient deficiencies, and elevated markers of infection and inflammation, was compared among groups through the use of x-square tests. Continuous variables (i.e., concentrations of each biomarker of nutritional status, infection, and inflammation) were compared with the use of Spearman correlations. To examine the effects of elevated APP and asymptomatic malaria on the relation between different biomarkers of iron status and the extent to which the correction factors affected this relation we attempted to fit change-point regression models (PROC NLIN; SAS Institute), but the models did not converge. Therefore, locally weighted scatter plot smoothing curves (a nonparametric regression method) and linear regression were used to examine the relation between biomarkers (pF-sTfR, Hb-pF, and sTfR-Hb), and Spearman rank correlation coefficients were calculated.
All statistical analyses were completed through the use of SAS System for Windows release 9.3 (SAS Institute). A value of P < 0.05 was considered statistically significant. Data are presented as means 6 SDs (AGP, Hb, pZn) or geometric means 6 SEMs (CRP, HRP2, pF, sTfR, RBP), unless otherwise noted.
Results
The study population has been described in detail elsewhere (16) . Basic demographic characteristics and biomarkers of infection and inflammation among study participants are presented in Table 1 . The prevalence of elevated AGP was marginally higher among young children 12-23 mo of age than among infants 6-11 mo of age (57.4% vs. 48.7%; P = 0.07). There was no age-related difference for CRP or HRP2.
Relations among markers of infection and inflammation and nutritional status. There were significant positive correlations among CRP, AGP, and HRP2 (r = 0.47-0.64, P < 0.0001), and CRP and AGP were higher in children with asymptomatic malaria than those without (CRP: 4.6 6 0.3 mg/L vs. 1.2 6 0.1 mg/L, P < 0.0001; AGP: 1.2 6 0.3 g/L vs. 0.9 6 0.2 g/L, P < 0.0001). In addition, the distributions of infection stage differed by HRP2 status ( Table 2) ; however, CRP and AGP concentrations within categorical APP groups did not differ between those with and without elevated HRP2, with the exception of CRP in the reference groups (1.6 6 0.2 mg/L vs. 0.7 6 0.05 mg/L, with and without elevated HRP2, respectively; P < 0.0001). CRP, AGP, and HRP2 were each positively correlated with pF and sTfR and negatively correlated with Hb, RBP, and pZn (Supplemental Table 1 ).
Biomarkers of iron status among children by APP and HRP2 status. The unadjusted geometric mean pF concentration differed significantly by APP status ( Table 3) . Within each of the APP categories, pF was 2.0-2.9 times higher among those with elevated HRP2 than among those without; therefore, even after adjusting for APP, children with elevated HRP2 had higher pF concentrations than children without detectable HRP2. Although geometric mean pF concentrations differed significantly by sex (25.3 6 1.6 mg/L vs. 33.2 6 2.2 mg/L, male and female children, respectively; P = 0.004) and by age (32.9 6 2.3 mg/L vs. 26.2 6 1.6 mg/L, 6-11 mo and 12-23 mo, respectively; P = 0.016) when controlling for APP and HRP2, neither sex nor age modified the relations among APP, HRP2, and pF. Before adjusting for APP status, 23.3% of children were identified as ID (pF < 12 mg/L); significantly fewer children with elevated HRP2 had low pF than those without elevated HRP2 (Table 2) . After adjusting pF concentrations to the ''reference'' group with the use of APP categories, 38.4% of children were identified as ID; however, even after adjusting for APP a significantly smaller percentage of children with elevated HRP2 had low pF compared with those without elevated HRP2. Adjusting pF concentrations through the use of specific correction factors based on both HRP2 and APP status, in which all values were adjusted to the geometric mean pF concentration among children with nonelevated CRP, AGP, and HRP2, resulted in a pF concentration of 12.6 6 0.6 mg/L and an estimated prevalence of ID of 50.6%. Of the children in the study, 90.1% had elevated sTfR (>8.3 mg/L), indicative of ID and/or increased erythropoiesis. sTfR differed significantly by APP category (Table 4) ; however, when HRP2 status was included in the model the association between APP category and sTfR was no longer significant, suggesting that elevated sTfR may have been due to increased erythropoiesis in response to malaria, rather than to inflammation per se. sTfR was 1.5 times higher among children with asymptomatic malaria compared with children with no evidence of malaria infection, and this relation did not differ by age or sex. Adjusting sTfR for HRP2 status resulted in a mean sTfR concentration of 12.3 6 0.2 mg/L; the estimated prevalence of ID remained elevated at 83.8%.
Children with elevated CRP or AGP, or both, had significantly lower Hb than those with neither APP elevated ( Table 5 ), suggesting that a portion of the observed anemia may be due to the presence of infection in this population. Individuals with elevated HRP2 had lower Hb than those with nonelevated HRP2, independent of APP status. Children with elevated HRP2 were more likely to be anemic and were more likely to have 3 APP and ferritin, n = 444; APP, ferritin, and HRP2, n = 437. 4 APP correction factors were calculated as the ratio of the geometric mean value of the biomarker for the reference group (neither APP elevated) to each APP group. 5 APP/HRP2 correction factors were calculated as the ratio of the geometric mean value of the biomarker for the reference group (neither APP nor HRP2 elevated; i.e., pF = 12.6 μg/L) to each APP by HRP2 group. 6 Values by HRP2 status controlling for elevated APP are geometric means 6 SEMs. Labeled geometric means in a row without a common letter differ, P , 0.05. There was no interaction between APP category and malaria variable; thus, within-row labeled geometric means reflect the main effects model only.
Infection, inflammation, and micronutrient status 2053 moderate or severe anemia than those with nonelevated HRP2 (Table 2) .
Relations among indicators of iron status. Before adjusting indicators of iron status for asymptomatic malaria infection and inflammation (APP and/or HRP2), pF was not correlated with sTfR (r s = 20.02, P = 0.60; Figure 1A ). The lack of this expected relation resulted from increased pF and sTfR concentrations among those with elevated HRP2 compared with those with nonelevated HRP2 (Figure 1B ), because there was no effect modification by HRP2 status (ANOVA, P = 0.26 [for interaction]). When pF was adjusted for both APP and HRP2 and sTfR was adjusted for HRP2, the 2 indicators were negatively associated (r s = 20.40, P < 0.0001; Figure 1C ), and the relation did not differ by HRP2 status. Before adjusting pF for subclinical infection and inflammation, pF concentrations were inversely associated with Hb concentrations (r s = 20.20, P < 0.0001;
Supplemental Figure 1A ), because of lower Hb among children with elevated HRP2 for the same concentration of pF (Supplemental Figure 1B ). Adjusting pF for categorical APP status resulted in a lack of association between pF and Hb (r s = 20.02, P = 0.64; Supplemental Figure 1C , D). Adjusting pF for both APP and HRP2 resulted in a positive association between pF and Hb, because of an adjustment-associated reduction in pF among those with elevated HRP2 (r s = 0.12, P = 0.02; Supplemental Figure 1E , F). Before adjusting sTfR for HRP2, sTfR was negatively associated with Hb (r s = 20.51, P < 0.0001; Supplemental Figure 2A ). Children with elevated HRP2 had higher sTfR for the same degree of anemia when compared with those who did not have elevated HRP2 (Supplemental Figure  2B ). sTfR and Hb remained negatively associated after adjusting for HRP2 (r s = 20.37, P < 0.0001; Supplemental Figure 2C ).
Prevalence of ID by indicator and infection adjustment.
The unadjusted prevalence of ID with the use of conventional cutoffs varied widely by indicator method, ranging from 23.4% (unadjusted pF < 12 mg/L) to 90.1% (unadjusted sTfR > 8.3 mg/ L). Among children with elevated HRP2, the range of estimated prevalence of ID was even wider, from 5.2% (unadjusted pF < 12 mg/L) to 97.6% (unadjusted sTfR > 8.3 mg/L; Table 2 ). Adjusting the indicators for APP and/or HRP2, prevalence estimates of ID based on pF and sTfR were 50.6% and 83.8%, respectively. When sTfR was adjusted for HRP2 in the present study, and a cutoff of 10.3 mg/L was applied, the prevalence of ID was estimated to be 62.1%. However, the same children were not identified as being ID by both indicators (pF and sTfR; sensitivity: 58.7%, specificity: 62.7%).
Biomarkers of vitamin A and zinc status among children by APP and HRP2 status. RBP concentration differed significantly by CRP, but not AGP status ( Table 6 ). After adjusting RBP for APP, children with elevated HRP2 had lower RBP than children without elevated HRP2. Before adjusting for elevated APP, 43.7% of children were identified as vitamin A deficient; after adjusting RBP concentrations for APP the estimated prevalence of vitamin A deficiency decreased to 33.1%. However, a significantly greater percentage of children with elevated HRP2 had low RBP compared with those without elevated 4 APP correction factors were calculated as the ratio of the geometric mean value of the biomarker for the reference group (neither APP elevated) to each APP group. 5 APP/HRP2 correction factors were calculated as the ratio of the geometric mean value of the biomarker for the reference group (neither APP nor HRP2 elevated; i.e., sTfR = 11.8 mg/L) to each APP by HRP2 group. 6 Values by HRP2 status are geometric means 6 SEMs. Labeled geometric means in a row without a common letter differ, P , 0.05. There was no interaction between APP category and malaria variable; thus, within-row labeled geometric means reflect the main effects model only. 4 Values by HRP2 status controlling for elevated APP are geometric means 6 SEMs.
Labeled geometric means in a row without a common letter differ, P , 0.05. There was no interaction between APP category and malaria variable; thus, within-row labeled geometric means reflect the main effects model only.
HRP2 (44.8% vs. 22.7%; P < 0.0001). Adjusting RBP values through the use of correction factors based on both HRP2 and APP status resulted in a RBP concentration of 0.96 6 0.01 mmol/L and an estimated prevalence of vitamin A deficiency of 27.7%. The mean pZn was 62.9 6 11.6 mg/dL, and 62.7% of children had pZn < 65 mg/dL. pZn was significantly lower in those with elevated APP; the ratios of pZn of the reference group vs. the incubation, early convalescence, and late convalescence groups were 1.06, 1.08, and 1.04, respectively. After adjusting for APP, there were no differences in pZn among those with and without elevated HRP2 (64.9 6 12.7 mg/dL and 64.9 6 11.1 mg/dL, respectively; P = 0.98).
Discussion
The results of this study indicate that Hb and RBP concentrations were significantly lower and pF and sTfR concentrations were significantly higher among children with asymptomatic malaria, independent of the effects of the acute phase response (to the extent that it is captured by categories of elevated CRP and/or AGP). pZn concentrations, on the other hand, were not affected by asymptomatic malaria after controlling for APP.
The interpretation of biomarkers of nutritional status among some populations in low-income countries is challenging because of the confounding effects of subclinical infection and inflammation. The findings of the present study are important because they indicate that adjusting biomarkers of iron and vitamin A status mathematically based solely on APP, as has been widely adopted in the field (26) , may underestimate the prevalence of ID and overestimate the prevalence of vitamin A deficiency, in settings with a high prevalence of asymptomatic malaria. The present study was conducted among infants and young children, who are particularly vulnerable to micronutrient deficiencies and infections. Therefore, it is possible that in populations with a relatively higher immunity to malaria (e.g., school-age children and nonpregnant adults in holoendemic regions) and a lower burden of asymptomatic infection, or a lower prevalence of ID and anemia, the relation between asymptomatic malaria status, APP, and indicators of micronutrient status, or the impact of APP and HRP2 on the estimated prevalence of micronutrient deficiencies, would be attenuated (27) .
The primary limitation of this study is the lack of definitive measures of micronutrient status (i.e., bone marrow iron, hepatic vitamin A) because of ethical considerations and logistical constraints or the nonexistence of such a reference indicator (i.e., zinc status). Therefore, because individual micronutrient status is unknown and data are cross-sectional, correction factors rely on the assumption that absolute micronutrient status is the same in children with and without asymptomatic malaria (and with and without elevated APP), that the measured APPs capture the full effects of the acute phase response on measured biomarkers, and that intergroup differences in micronutrient concentrations are solely due to differences in functional micronutrient status. Furthermore, the present study could have benefited from the measurement of current asymptomatic malaria [i.e., quantification of parasite density by microscopy or by molecular biology methods (qPCR) vs. detection of the HRP2 antigen, which may remain positive for up to 28 d after clearance of the parasitemia], other parasitic infections, hemoglobinopathies, and/or the rate of erythropoiesis, which may have assisted in the interpretation of micronutrient status and causes of anemia. However, the indicators measured in this study are those most commonly used in population-based screening programs in low-income settings where infection and inflammation are prevalent. This study was strengthened by its large sample size and the high prevalence of infection and inflammation, which allowed us to examine the associations between asymptomatic malaria and indicators of micronutrient status among the 4 APP categories. However, consistent with other studies that have used the correction factor method (12) , the sample size in the incubation group (elevated CRP only) is quite small, limiting the accuracy of estimates in this group.
In a recent meta-analysis on the effects of elevated APP on pF, correction factors were 0.77, 0.53, 0.75, and 1.0 for the incubation, early convalescence, late convalescence, and reference subgroups, respectively (3); a similar pattern of differences was observed in the present study, not accounting for asymptomatic malaria. However, we observed an additional significant negative association between elevated HRP2 and pF, which was independent of elevated APP. After adjusting for APP, children with elevated HRP2 had pF 2.12 times those with nonelevated HRP2, similar to the relation observed by Verhoef et al. (7) and Grant et al. (11) . APP-adjusted pF underestimated the prevalence of ID by 15.9 percentage points compared to estimates based on APP-HRP2-adjusted pF. The hypoferremia of inflammation, likely cytokine-and hepcidin-mediated, is associated with increased ferritin synthesis and iron sequestration in the liver and tissues of the mononuclear phagocyte system (9, 26) . In the present study, the large increase in pF observed among children with asymptomatic malaria beyond the associations with elevated APP is possibly due to incomplete capture of the acute phase response by categorical CRP and AGP and/or dyserythropoiesis, hemolysis, and increased clearance of parasitized and nonparasitized erythrocytes, which are mediated by malaria-induced mechanisms (9) .
In the present study, asymptomatic malaria was associated with increased sTfR; similar observations have been previously reported among infants and young children in malaria holoendemic regions (7, (28) (29) (30) . Our results indicate that APP were not associated with sTfR after controlling for malaria, a finding that has been reported in some (7) but not all (12, 28, (31) (32) (33) studies. However, only 1 of the aforementioned studies (12) controlled for the impact of asymptomatic malaria on sTfR. Despite these reported associations between APP and sTfR in malaria endemic regions, sTfR is not an APP, and it is not generally thought to be directly affected by the acute phase response. Therefore, it should not be mathematically adjusted to ''correct'' for elevated APP (34) . Our results indicate that among children without asymptomatic malaria, sTfR likely reflects iron availability for erythropoiesis and is a valid biomarker of iron status. However, among children with asymptomatic malaria, sTfR may reflect increased erythrocyte breakdown and increased or ineffective erythropoiesis resulting from malaria-induced hemolysis, in addition to functional iron deficits (7, 9, 35) . Therefore, adjusting sTfR for HRP2 may correct for the effects of malaria-induced alterations in erythropoietic activity, thus potentially allowing us to isolate the effects of ID on sTfR and improve the validity of this biomarker in determining iron status.
The indicators of iron status analyzed in this study (unadjusted and adjusted pF and sTfR) produced very different estimates of ID through the use of conventionally defined cutoffs highlighting the difficulties of diagnosing ID in individuals for the purpose of targeted iron supplementation, as recommended by the WHO (36) . Similar disparities among different indicators of iron status have been observed by other researchers (12, 28, 31, 33, 37) . The cutoff used to define ID based on elevated sTfR was >8.3 mg/L, the upper limit of a reference range established based on values from healthy adults in the United States and validated for the laboratory in which our samples were analyzed (18) . It is possible that an age-dependent cutoff is necessary (22) . Despite the differences in prevalence estimates between the indicators of iron status, both indicate that ID is a major public health problem in this population and would likely have the same implications for public policies.
RBP and retinol have been consistently shown to be negatively associated with elevated APP, and although reductions in RBP and retinol have been previously observed with both symptomatic and asymptomatic malaria infections, they have largely been attributed to the inflammatory response (13) (14) (15) . Therefore, after adjusting for APP, RBP and retinol are thought to be useful indicators of vitamin A status and deficiency (23) . However, in the current study, we observed an association between elevated HRP2 and RBP, even after adjusting for elevated APP. During an acute phase response, lower RBP and retinol may result from decreased synthesis of RBP, an impaired ability to release retinol from the liver, or the increased removal of RBP and retinol from the vascular space resulting in greater availability to the tissues (13, 15, 38) . It is possible that the additional effects of asymptomatic malaria on reductions in RBP observed in the present study may be caused by differences in the acute phase response between those with and without malaria (not reflected in CRP and AGP) or by disease-specific differences in the synthesis, turnover, and distribution of RBP. Reductions in RBP and retinol observed during the acute phase response and asymptomatic malarial infection are most likely transitory, and concentrations of retinol have been shown to normalize after 4 APP correction factors were calculated as the ratio of the geometric mean value of the biomarker for the reference group (neither APP elevated; i.e., RBP = 0.97 μmol/L) to each APP group. 5 APP/HRP2 correction factors were calculated as the ratio of the geometric mean value of the biomarker for the reference group (neither APP nor HRP2 elevated) to each APP by HRP2 group. 6 Values by HRP2 status controlling for elevated APP are geometric means 6 SEMs. Labeled geometric means in a row without a common letter differ, P , 0.05. There was no interaction between APP category and malaria variable; thus, within-row labeled geometric means reflect the main effects model only.
clearance of malaria parasitemia or other infections (39) . Thus, the prevalence of vitamin A deficiency in a population is likely overestimated if statistical adjustments are not used to correct for both APP and asymptomatic malaria. In the present study, adjusting for APP alone vs. adjusting for both APP and HRP2 would overestimate the prevalence of deficiency by 46%. However, the prevalence of vitamin A deficiency in this population, even after adjusting for both APP and HRP2, is likely indicative of a public health problem (23, 40) , despite semiannual high-dose vitamin A supplementation. In the present study, pZn was negatively associated with APP and comparable to the decrease in pZn associated with infection and inflammation observed by other researchers (8, 41, 42) . However, in contrast to the other indicators of micronutrient status included in these analyses, pZn did not differ by asymptomatic malaria status when controlling for APP. Although CRP and parasite density were independently associated with pZn in 1 study conducted among infants and young children with uncomplicated acute malaria (43), these results, which are in contrast to those of the present study, are likely attributable to differences in the degree of the immune response and micronutrient metabolism between clinical and asymptomatic malaria.
In conclusion, the present research highlights the difficulties in using currently available biomarkers to accurately determine micronutrient status among infants and young children in malaria endemic regions with a high prevalence of asymptomatic infection and inflammation. Prospective studies are necessary to discern the intraindividual effects of elevated APP and asymptomatic malaria and time-dependent changes in infection status on indicators of micronutrient status, which may be occurring independently of any alterations in actual micronutrient status and deficiency. Although the use of correction factors is an acceptable short-term approach until additional biomarkers are discovered, indicators of both APP and asymptomatic malaria in endemic regions should to be included in the assessment of micronutrient status to assess the prevalence of iron and vitamin A deficiencies and assist in the evaluation of the efficacy or effectiveness of micronutrient interventions.
